Tukaram Mundhe clarifies he is not targeting Shah Rukh Khan or Ajay Devgn, announces FDA issued notices regarding surrogacy.

FDA Targets Celebrity Endorsements Amid Surrogate Advertising Concerns

The Food and Drug Administration (FDA) of India has issued notices to high-profile actors, including Shah Rukh Khan, Ajay Devgn, and Tiger Shroff, concerning their involvement in advertisements that may violate regulations on surrogate advertising. FDA Commissioner Tukaram Mundhe clarified that the intent of these notices is not to single out any specific individual but to ensure compliance with advertising standards that protect consumer interests.

Surrogate advertising refers to promoting a product under the guise of an unrelated item, often utilized when the actual product is banned from being directly advertised. This issue has gained attention amid widespread concerns about the ethics and legality of such marketing practices, particularly in the context of the entertainment industry.

Mundhe emphasized the FDAs commitment to addressing misleading advertising practices and stated that the actors have yet to respond to the notices. There is an ongoing dialogue around how these surrogate ads function and their impact on consumers, with industry experts like Prahlad Kakar discussing the need for clearer regulations in this domain.

As celebrities often wield significant influence over public perception, the FDA aims to ensure that they uphold standards of honesty and transparency in advertisements, especially regarding health-related products. The agencys scrutiny reflects a broader trend towards increased regulation in advertising practices across various industries.

The outcome of this situation remains to be seen as responses from the actors and potential regulatory reforms are awaited.